Overview What is the TIPAC? Why do NTD programmes use it? What does it look like? What reports does it generate? (This is not a full training) 2
What is the TIPAC? 3
NTD Tool for Integrated Planning and Costing (NTD-TIPAC) WHO-recommended tool. Inputs, analyzes, and presents NTD costs and funding gap data in a variety of ways. For program management and communication with donors and partners. Used in conjunction with existing national NTD strategic plans and budgets. 4
Starting a Programme Situation analysis National NTD Master Plan Setting up Key M&E Indicators Epidemiological data collected by mapping Mapping Stakeholder meeting Managing MDAs Surveillance Sentinel sites 5
Countries That Have Implemented TIPAC 6
Why do national NTD programmes use the TIPAC? 7
TIPAC Objectives Facilitate identification of integration opportunities across activities and diseases. Rational annual work planning. 8
TIPAC Objectives Estimate the cost of implementing integrated NTD control programs in accordance with international guidelines and national plans of action. Program Costs 9
TIPAC Objectives Quantify existing funds and resources from government and other sources for national plans of action. Program Costs Existing Funds and Resources 10
TIPAC Objectives Identify Funding Gaps. Program Costs Existing Funds and Resources Funding Gap 11
TIPAC Objectives Generate projections of drug needs for 5 years. Generate forms required in WHO s Joint Application Package: Joint Request for Selected Medicines Annual Work Plan 12
What does the TIPAC look like? 13
14
15
Entering Population and NTD Data 16
Enter Planned Activities 17
Enter Drug Information 1. Select donor 2. Select medicine Contribution of drug donors are added 3. Enter quantity Medicine gaps are auto-estimated 18
Funders 19
What reports does the TIPAC generate? 20
Report: Total Cost by Activity Total costs 6,276,462 100% Districts Total Percent Drug logistics 584,480 9% MDA 349,522 6% MDA registration 3,898,636 62% Training 580,100 9% Mapping 120,000 2% M&E 0 0% Morbidity Mx 90,000 1% Social mobilization 282,603 5% Strategic planning 371,120 6% Vector control 0 0% Mapping 2% Training 9% M&E 0% Morbidity Mx 1% Social mobilization 5% Vector control 0% Strategic planning 6% MDA registration 62% Drug logistics 9% MDA 6% 21
Report: Total Program Funding Total program costs 13,801,262 100% Total program funding 12,457,992 90% Funding gap* 1,343,270 10% Program Funding Sources* Total Percent Government funding 1,440,515 10% USAID 0 0% Unite for Children 94,785 1% Eliminate NTDs 3,670,892 27% Government salaries 7,251,800 52% Government Saleries 52% Funding Gap* 10% Government Funding 10% Eliminate Neglected Disease 27% Total Program Funding USAID 0% Unite For Children 1% 22
Report: Five Year Cost Projections Summary / Activity / Sub-activity FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 TOTAL TOTAL 531,069,572 552,666,869 614,328,443 642,120,993 618,550,584 2,958,736,460 Drug Acquisition 524,520,110 546,524,090 608,142,370 636,976,566 614,705,702 2,930,868,838 Activity costs 6,549,462 6,142,779 6,186,073 5,144,427 3,844,882 27,867,622 23
Report: PC Drugs Needed, Acquired and Gap 24
Report: Annual Work Plan Matrix 25
Report: JRSM 26
(Additional Diseases can be Added) 27
Summary Facilitate identification of integration opportunities across activities and diseases. Assists with, but does not replace annual work plans. Generate useful reports and forms for WHO s Joint Application Package. Program Costs Existing Funds and Resources Funding Gap 28